From Biomarker to Market: Optimizing Access for Precision Therapies, Upcoming Webinar Hosted by Xtalks

In this free webinar, see how to navigate US payer expectations for biomarker-driven therapies. Attendees will learn how to address evidence gaps in small, targeted populations and validate endpoints. The featured speakers will discuss how to use real-world data and external comparators to demonstrate value. Attendees will also discover how to build integrated, cross-functional evidence strategies that support reimbursement and access.

TORONTO, June 10, 2026 /PRNewswire/ -- Precision medicine is redefining what's clinically possible, but not what's commercially guaranteed. In the US, biomarker-driven and companion diagnostic–led therapies face persistent access barriers, including fragmented coverage, pricing pressures and evidence limitations driven by small, targeted populations and reliance on surrogate endpoints. As a result, clinical efficacy alone is no longer sufficient to secure payer-recognized value or reimbursement.

This webinar brings together cross-functional experts to explore how developers can close this gap: designing data and evidence strategies that translate precision innovation into real-world, decision-ready value across payers, providers and patients.

Attendees will learn how to:

• Navigate US access barriers and evolving payer expectations for precision therapies
• Understand and address evidence gaps in small, biomarker-defined populations
• Leverage real-world data and external comparators to validate endpoints and demonstrate value
• Integrate patient-centered evidence to strengthen differentiation and decision relevance
• Build multi-stakeholder evidence strategies, with tailored approaches for rare oncology and neurology

By the end of this session, attendees will have a clear, practical framework for transforming precision therapies from promising science into payer-relevant, evidence-backed value propositions, enabling more predictable access, stronger reimbursement outcomes and sustainable commercial success.

Register for this webinar to learn how precision therapies can move from promising science to payer-relevant, evidence-backed value propositions that support access and reimbursement.

Join experts from Thermo Fisher Scientific, Adam Petrich, MD, Vice President, Oncology, Medical Science and Strategy; Priya Jain, MS, MBA, Executive Director, PPD Evidera Health Economics & Market Access; John Hamlet, Executive Director, Neuroscience Pillar Head; Amanda Pulfer, BA, Executive Director, Integrated Solutions, RWE, PPD Evidera Real-World Data & Scientific Solutions; and Elizabeth Dansie Bacci, PhD, Senior Research Scientist, PPD Evidera Patient-Centered Research, for the live webinar on Tuesday, June 30, 2026, at 11am EDT (5pm CEST/EU-Central).

For more information, or to register for this event, visit From Biomarker to Market: Optimizing Access for Precision Therapies.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com

For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected] 

SOURCE Xtalks